Olli Taneli Pentikäinen (Olli T Pentikäinen, Olli Pentikäinen)

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 23

Top Venues

Molecules (Basel, Switzerland)

Chemical biology & drug design

Journal of chemical information and modeling

Xenobiotica; the fate of foreign compounds in biological systems

Aurlide ltd.

Åbo Akademi University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Aurlide ltd. Jan 25 2019

Finland

CEO :: Drug discovery

University of Turku Aug 01 2017

Finland

Professor of Medicinal Chemistry :: Institute of Biomedicine

University of Jyväskylä Jan 01 2011

Finland

Associate Professor in Cell and Molecular Biology :: Department of Biological and Environmental Science

FBD ltd. Sep 09 1999 - Dec 31 2005

Finland

Manager of Molecular Discovery

Education History

Åbo Akademi University Jun 16 1997 - Dec 16 2003

Finland

PHD :: Biochemistry and Pharmacy

University of Joensuu Sep 01 1987

Finland

MSC :: Chemistry

Publications

Elmeri Matias Jokinen, Miika Niemeläinen, Sami T Kurkinen, Jukka V Lehtonen, Sakari T Lätti, Pekka A Postila, Olli Taneli Pentikäinen, Sanna P Niinivehmas
Virtual Screening Strategy to Identify Retinoic Acid-Related Orphan Receptor γt Modulators. Molecules (Basel, Switzerland) 28 (8) (2023)
Elmeri Matias Jokinen, Miika Niemeläinen, Sami T Kurkinen, Jukka V Lehtonen, Sakari T Lätti, Pekka A Postila, Olli Taneli Pentikäinen, Sanna P Niinivehmas
Virtual Screening Strategy to Identify Retinoic Acid-Related Orphan Receptor γt Modulators. Molecules (Basel, Switzerland) 28 (8) (2023)
Elmeri Matias Jokinen, Miika Niemeläinen, Sami T Kurkinen, Jukka V Lehtonen, Sakari T Lätti, Pekka A Postila, Olli Taneli Pentikäinen, Sanna P Niinivehmas
Virtual Screening Strategy to Identify Retinoic Acid-Related Orphan Receptor γt Modulators. Molecules (Basel, Switzerland) 28 (8) (2023)
Elmeri Matias Jokinen, Miika Niemeläinen, Sami T Kurkinen, Jukka V Lehtonen, Sakari T Lätti, Pekka A Postila, Olli Taneli Pentikäinen, Sanna P Niinivehmas
Virtual Screening Strategy to Identify Retinoic Acid-Related Orphan Receptor γt Modulators. Molecules (Basel, Switzerland) 28 (8) (2023)
John Marshal Jayaraj, Muralidharan Jothimani, Chella Perumal Palanisamy, Olli Taneli Pentikäinen, Mehboobali Pannipara, Abdullah Godran Al-Sehemi, Karthikeyan Muthusamy, Krishnasamy Gopinath
Computational Study on the Inhibitory Effect of Natural Compounds against the SARS-CoV-2 Proteins. Bioinorganic chemistry and applications 2022 (2022)
Sami T Kurkinen, Jukka V Lehtonen, Olli Taneli Pentikäinen, Pekka A Postila
Ligand-Enhanced Negative Images Optimized for Docking Rescoring. International journal of molecular sciences 23 (14) (2022)
Sami T Kurkinen, Jukka V Lehtonen, Olli Taneli Pentikäinen, Pekka A Postila
Optimization of Cavity-Based Negative Images to Boost Docking Enrichment in Virtual Screening. Journal of chemical information and modeling 62 (4) (2022)
Joanna Małolepsza, Aleksandra Marchwicka, Remigiusz A Serwa, Sanna P Niinivehmas, Olli Taneli Pentikäinen, Edyta Gendaszewska-Darmach, Katarzyna M Błażewska
Rational design, optimization, and biological evaluation of novel α-Phosphonopropionic acids as covalent inhibitors of Rab geranylgeranyl transferase. Journal of enzyme inhibition and medicinal chemistry 37 (1) (2022)
Risto O Juvonen, Elmeri M Jokinen, Juhani Huuskonen, Olli Kärkkäinen, Hannu Raunio, Olli Taneli Pentikäinen
Molecular docking and oxidation kinetics of 3-phenyl coumarin derivatives by human CYP2A13. Xenobiotica; the fate of foreign compounds in biological systems 51 (11) (2021)
Sanna Niinivehmas, Olli Taneli Pentikäinen
Coumarins as Tool Compounds to Aid the Discovery of Selective Function Modulators of Steroid Hormone Binding Proteins. Molecules (Basel, Switzerland) 26 (17) (2021)
Risto Olavi Juvonen, Mira Ahinko, Elmeri M Jokinen, Juhani Huuskonen, Hannu Raunio, Olli Taneli Pentikäinen
Substrate Selectivity of Coumarin Derivatives by Human CYP1 Enzymes: In Vitro Enzyme Kinetics and In Silico Modeling. ACS omega 6 (17) (2021)
Sakari T Lätti, Sanna Niinivehmas, Olli Taneli Pentikäinen
Sdfconf: A Novel, Flexible, and Robust Molecular Data Management Tool. Journal of chemical information and modeling 62 (1) (2021)
Risto Olavi Juvonen, Elmeri Matias Jokinen, Adeel Javaid, Marko Lehtonen, Hannu Raunio, Olli Taneli Pentikäinen
Inhibition of human CYP1 enzymes by a classical inhibitor α-naphthoflavone and a novel inhibitor N-(3, 5-dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study. Chemical biology & drug design 95 (5) (2020)
Hannu Raunio, Olli Taneli Pentikäinen, Risto O Juvonen
Coumarin-Based Profluorescent and Fluorescent Substrates for Determining Xenobiotic-Metabolizing Enzyme Activities In Vitro. International journal of molecular sciences 21 (13) (2020)
Risto O Juvonen, Olli Taneli Pentikäinen, Juhani Huuskonen, Juri Timonen, Olli Kärkkäinen, Aki Heikkinen, Muluneh Fashe, Hannu Raunio
In vitro sulfonation of 7-hydroxycoumarin derivatives in liver cytosol of human and six animal species. Xenobiotica; the fate of foreign compounds in biological systems 50 (8) (2020)
Santeri Maatsola, Sami Kurkinen, Marica T Engström, Thomas K M Nyholm, Olli Taneli Pentikäinen, Juha-Pekka Salminen, Sauli Haataja
Inhibition of Pneumolysin Cytotoxicity by Hydrolysable Tannins. Antibiotics (Basel, Switzerland) 9 (12) (2020)
Mira Ahinko, Sami T Kurkinen, Sanna P Niinivehmas, Olli Taneli Pentikäinen, Pekka A Postila
A Practical Perspective: The Effect of Ligand Conformers on the Negative Image-Based Screening. International journal of molecular sciences 20 (11) (2019)
Elmeri Matias Jokinen, Pekka A Postila, Mira Ahinko, Sanna Niinivehmas, Olli Taneli Pentikäinen
Fragment- and negative image-based screening of phosphodiesterase 10A inhibitors. Chemical biology & drug design 94 (4) (2019)
Sami T Kurkinen, Sakari Lätti, Olli Taneli Pentikäinen, Pekka A Postila
Getting Docking into Shape Using Negative Image-Based Rescoring. Journal of chemical information and modeling 59 (8) (2019)
Risto Olavi Juvonen, Sanna Rauhamäki, Sami Kortet, Sanna Niinivehmas, Johanna Troberg, Aleksanteri Petsalo, Juhani Huuskonen, Hannu Raunio, Moshe Finel, Olli Taneli Pentikäinen
Molecular Docking-Based Design and Development of a Highly Selective Probe Substrate for UDP-glucuronosyltransferase 1A10. Molecular pharmaceutics 15 (3) (2018)
Mira Ahinko, Sanna Niinivehmas, Elmeri Jokinen, Olli Taneli Pentikäinen
Suitability of MMGBSA for the selection of correct ligand binding modes from docking results. Chemical biology & drug design 93 (4) (2018)
Sanna Niinivehmas, Pekka A Postila, Sanna Rauhamäki, Elangovan Manivannan, Sami Kortet, Mira Ahinko, Pasi Huuskonen, Niina Nyberg, Pasi Koskimies, Sakari Lätti, Elina Multamäki, Risto O Juvonen, Hannu Raunio, Markku Pasanen, Juhani Huuskonen, Olli Taneli Pentikäinen
Blocking oestradiol synthesis pathways with potent and selective coumarin derivatives. Journal of enzyme inhibition and medicinal chemistry 33 (1) (2018)
Risto O Juvonen, Mira Ahinko, Juhani Huuskonen, Hannu Raunio, Olli Taneli Pentikäinen
Development of new Coumarin-based profluorescent substrates for human cytochrome P450 enzymes. Xenobiotica; the fate of foreign compounds in biological systems 49 (9) (2018)

Olli Taneli Pentikäinen.css-eqlu8i{font-size:small;padding-left:4px;} (Olli T Pentikäinen, Olli Pentikäinen)

Publication Activity (10 Years)

Top Topics

Top Venues

Olli Taneli Pentikäinen (Olli T Pentikäinen, Olli Pentikäinen)